株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心房細動治療薬の市場規模:製品別、心房細動タイプ別、用途別、投与ルート別、エンドユース別業界分析レポート、地域別見通し、潜在的用途、価格動向、競合市場シェアおよび予測

Atrial Fibrillation Drugs Market Size By Products, Atrial Fibrillation Type, Application Route of Administration End-use Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019-2025

発行 Global Market Insights Inc. 商品コード 862124
出版日 ページ情報 英文 350 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
心房細動治療薬の市場規模:製品別、心房細動タイプ別、用途別、投与ルート別、エンドユース別業界分析レポート、地域別見通し、潜在的用途、価格動向、競合市場シェアおよび予測 Atrial Fibrillation Drugs Market Size By Products, Atrial Fibrillation Type, Application Route of Administration End-use Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019-2025
出版日: 2019年04月22日 ページ情報: 英文 350 Pages
概要

当レポートでは、世界の心房細動治療薬市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 業界概要

  • 業界セグメンテーション
  • 業界動向
  • 影響因子
    • 成長促進因子
    • 成長阻害因子
  • 成長可能性分析
  • 世界の心房細動罹患率
  • 薬剤認可シナリオ
  • 投薬治療を受ける心房細動患者の割合
  • 直接経口抗凝固剤治療を受ける心房細動患者の割合
  • 価格分析
  • 市場シェア
  • 薬剤処方パターン
  • 技術動向
  • ポーターズ分析
  • 競合環境
  • PESTEL分析

第4章 製品別市場

  • 市場シェア
  • 抗不整脈剤
  • 抗凝固剤

第5章 タイプ別市場

  • 市場シェア
  • 発作性
  • 持続性
  • 常時

第6章 用途別市場

  • 市場シェア
  • 心調律管理
  • 心拍管理

第7章 投与ルート別市場

  • 市場シェア
  • 経口
  • 注射

第8章 エンドユース別市場

  • 市場シェア
  • 病院
  • 心臓センター
  • 外来外科センター
  • その他

第9章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

図表

Data Tables

  • TABLE 1: Atrial fibrillation drugs industry 360 degree synopsis, 2014 - 2025
  • TABLE 2: Global atrial fibrillation drugs market, 2014 - 2018 (USD Million)
  • TABLE 3: Global atrial fibrillation drugs market, 2019 - 2025 (USD Million)
  • TABLE 4: Global atrial fibrillation drugs market, by product, 2014 - 2018 (USD Million)
  • TABLE 5: Global atrial fibrillation drugs market, by product, 2019 - 2025 (USD Million)
  • TABLE 6: Global atrial fibrillation drugs market, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 7: Global atrial fibrillation drugs market, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 8: Global atrial fibrillation drugs market, by application, 2014 - 2018 (USD Million)
  • TABLE 9: Global atrial fibrillation drugs market, by application, 2019 - 2025 (USD Million)
  • TABLE 10: Global atrial fibrillation drugs market, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 11: Global atrial fibrillation drugs market, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 12: Global atrial fibrillation drugs market, by end-use, 2014 - 2018 (USD Million)
  • TABLE 13: Global atrial fibrillation drugs market, by product, 2019 - 2025 (USD Million)
  • TABLE 14: Global atrial fibrillation drugs market, by region, 2014 - 2018 (USD Million)
  • TABLE 15: Global atrial fibrillation drugs market, by region, 2017 - 2024 (USD Million)
  • TABLE 16: Industry impact forces
  • TABLE 17: Denmark atrial fibrillation reimbursement scenario
  • TABLE 18: Antiarrhythmic drugs used to treat atrial fibrillation
  • TABLE 19: Anticoagulant drugs used to treat atrial fibrillation
  • TABLE 20: Antiarrhythmic drugs market size, by region, 2014 - 2018 (USD Million)
  • TABLE 21: Antiarrhythmic drugs market size, by region, 2019 - 2025 (USD Million)
  • TABLE 22: Anticoagulant drugs market size, by region, 2014 - 2018 (USD Million)
  • TABLE 23: Anticoagulant drugs market size, by region, 2019 - 2025 (USD Million)
  • TABLE 24: Vitamin K antagonists (VKA) market size, by region, 2014 - 2018 (USD Million)
  • TABLE 25: Vitamin K antagonists (VKA) market size, by region, 2019 - 2025 (USD Million)
  • TABLE 26: Novel oral anticoagulants market size, by region, 2014 - 2018 (USD Million)
  • TABLE 27: Novel oral anticoagulants market size, by region, 2019 - 2025 (USD Million)
  • TABLE 28: Direct thrombin inhibitors market size, by region, 2014 - 2018 (USD Million)
  • TABLE 29: Direct thrombin inhibitors market size, by region, 2019 - 2025 (USD Million)
  • TABLE 30: Direct factor Xa inhibitors market size, by region, 2014 - 2018 (USD Million)
  • TABLE 31: Direct factor Xa inhibitors market size, by region, 2019 - 2025 (USD Million)
  • TABLE 32: Paroxysmal market size, by region, 2014 - 2018 (USD Million)
  • TABLE 33: Paroxysmal market size, by region, 2019 - 2025 (USD Million)
  • TABLE 34: Persistent market size, by region, 2014 - 2018 (USD Million)
  • TABLE 35: Persistent market size, by region, 2019 - 2025 (USD Million)
  • TABLE 36: Permanent market size, by region, 2014 - 2018 (USD Million)
  • TABLE 37: Permanent market size, by region, 2019 - 2025 (USD Million)
  • TABLE 38: Heart rhythm control market size, by region, 2014 - 2018 (USD Million)
  • TABLE 39: Heart rhythm control market size, by region, 2019 - 2025 (USD Million)
  • TABLE 40: Heart rate control market size, by region, 2014 - 2018 (USD Million)
  • TABLE 41: Heart rate control market size, by region, 2019 - 2025 (USD Million)
  • TABLE 42: Oral market size, by region, 2014 - 2018 (USD Million)
  • TABLE 43: Oral market size, by region, 2019 - 2025 (USD Million)
  • TABLE 44: Injectable market size, by region, 2014 - 2018 (USD Million)
  • TABLE 45: Injectable market size, by region, 2019 - 2025 (USD Million)
  • TABLE 46: Hospitals market size, by region, 2014 - 2018 (USD Million)
  • TABLE 47: Hospitals market size, by region, 2019 - 2025 (USD Million)
  • TABLE 48: Cardiac centers market size, by region, 2014 - 2018 (USD Million)
  • TABLE 49: Cardiac centers market size, by region, 2019 - 2025 (USD Million)
  • TABLE 50: Ambulatory surgical centers market size, by region, 2014 - 2018 (USD Million)
  • TABLE 51: Ambulatory surgical centers market size, by region, 2019 - 2025 (USD Million)
  • TABLE 52: Others market size, by region, 2014 - 2018 (USD Million)
  • TABLE 53: Others market size, by region, 2019 - 2025 (USD Million)
  • TABLE 54: North America atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)
  • TABLE 55: North America atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)
  • TABLE 56: North America atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 57: North America atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 58: North America atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 59: North America atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 60: North America atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 61: North America atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 62: North America atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 63: North America atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 64: North America atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 65: North America atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 66: North America atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 67: North America atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 68: North America atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 69: North America atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 70: U.S. atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 71: U.S. atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 72: U.S. atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 73: U.S. atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 74: U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 75: U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 76: U.S. atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 77: U.S. atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 78: U.S. atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 79: U.S. atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 80: U.S. atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 81: U.S. atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 82: U.S. atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 83: U.S. atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 84: Canada atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 85: Canada atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 86: Canada atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 87: Canada atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 88: Canada atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 89: Canada atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 90: Canada atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 91: Canada atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 92: Canada atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 93: Canada atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 94: Canada atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 95: Canada atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 96: Canada atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 97: Canada atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 98: Europe atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)
  • TABLE 99: Europe atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)
  • TABLE 100: Europe atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 101: Europe atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 102: Europe atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 103: Europe atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 104: Europe atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 105: Europe atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 106: Europe atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 107: Europe atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 108: Europe atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 109: Europe atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 110: Europe atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 111: Europe atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 112: Europe atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 113: Europe atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 114: Germany atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 115: Germany atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 116: Germany atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 117: Germany atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 118: Germany atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 119: Germany atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 120: Germany atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 121: Germany atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 122: Germany atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 123: Germany atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 124: Germany atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 125: Germany atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 126: Germany atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 127: Germany atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 128: UK atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 129: UK atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 130: UK atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 131: UK atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 132: UK atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 133: UK atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 134: UK atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 135: UK atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 136: UK atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 137: UK atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 138: UK atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 139: UK atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 140: UK atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 141: UK atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 142: France atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 143: France atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 144: France atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 145: France atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 146: France atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 147: France atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 148: France atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 149: France atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 150: France atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 151: France atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 152: France atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 153: France atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 154: France atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 155: France atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 156: Spain atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 157: Spain atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 158: Spain atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 159: Spain atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 160: Spain atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 161: Spain atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 162: Spain atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 163: Spain atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 164: Spain atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 165: Spain atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 166: Spain atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 167: Spain atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 168: Spain atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 169: Spain atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 170: Italy atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 171: Italy atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 172: Italy atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 173: Italy atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 174: Italy atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 175: Italy atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 176: Italy atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 177: Italy atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 178: Italy atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 179: Italy atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 180: Italy atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 181: Italy atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 182: Italy atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 183: Italy atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 184: Russia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 185: Russia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 186: Russia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 187: Russia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 188: Russia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 189: Russia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 190: Russia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 191: Russia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 192: Russia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 193: Russia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 194: Russia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 195: Russia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 196: Russia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 197: Russia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 198: Poland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 199: Poland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 200: Poland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 201: Poland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 202: Poland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 203: Poland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 204: Poland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 205: Poland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 206: Poland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 207: Poland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 208: Poland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 209: Poland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 210: Poland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 211: Poland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 212: Switzerland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 213: Switzerland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 214: Switzerland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 215: Switzerland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 216: Switzerland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 217: Switzerland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 218: Switzerland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 219: Switzerland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 220: Switzerland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 221: Switzerland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 222: Switzerland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 223: Switzerland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 224: Switzerland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 225: Switzerland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 226: Belgium atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 227: Belgium atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 228: Belgium atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 229: Belgium atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 230: Belgium atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 231: Belgium atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 232: Belgium atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 233: Belgium atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 234: Belgium atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 235: Belgium atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 236: Belgium atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 237: Belgium atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 238: Belgium atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 239: Belgium atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 240: Czech Republic atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 241: Czech Republic atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 242: Czech Republic atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 243: Czech Republic atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 244: Czech Republic atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 245: U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 246: Czech Republic atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 247: Czech Republic atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 248: Czech Republic atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 249: Czech Republic atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 250: Czech Republic atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 251: Czech Republic atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 252: Czech Republic atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 253: Czech Republic atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 254: Netherlands atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 255: Netherlands atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 256: Netherlands atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 257: Netherlands atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 258: Netherlands atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 259: Netherlands atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 260: Netherlands atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 261: Netherlands atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 262: Netherlands atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 263: Netherlands atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 264: Netherlands atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 265: Netherlands atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 266: Netherlands atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 267: Netherlands atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 268: Sweden atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 269: Sweden atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 270: Sweden atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 271: Sweden atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 272: Sweden atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 273: Sweden atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 274: Sweden atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 275: Sweden atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 276: Sweden atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 277: Sweden atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 278: Sweden atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 279: Sweden atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 280: Sweden atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 281: Sweden atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 282: Hungary atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 283: Hungary atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 284: Hungary atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 285: Hungary atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 286: Hungary atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 287: Hungary atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 288: Hungary atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 289: Hungary atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 290: Hungary atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 291: Hungary atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 292: Hungary atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 293: Hungary atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 294: Hungary atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 295: Hungary atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 296: Austria atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 297: Austria atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 298: Austria atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 299: Austria atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 300: Austria atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 301: Austria atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 302: Austria atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 303: Austria atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 304: Austria atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 305: Austria atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 306: Austria atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 307: Austria atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 308: Austria atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 309: Austria atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 310: Portugal atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 311: Portugal atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 312: Portugal atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 313: Portugal atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 314: Portugal atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 315: Portugal atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 316: Portugal atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 317: Portugal atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 318: Portugal atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 319: Portugal atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 320: Portugal atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 321: Portugal atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 322: Portugal atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 323: Portugal atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 324: Denmark atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 325: Denmark atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 326: Denmark atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 327: Denmark atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 328: Denmark atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 329: Denmark atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 330: Denmark atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 331: Denmark atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 332: Denmark atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 333: Denmark atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 334: Denmark atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 335: Denmark atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 336: Denmark atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 337: Denmark atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 338: Norway atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 339: Norway atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 340: Norway atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 341: Norway atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 342: Norway atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 343: Norway atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 344: Norway atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 345: Norway atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 346: Norway atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 347: Norway atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 348: Norway atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 349: Norway atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 350: Norway atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 351: Norway atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 352: Finland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 353: Finland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 354: Finland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 355: Finland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 356: Finland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 357: Finland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 358: Finland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 359: Finland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 360: Finland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 361: Finland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 362: Finland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 363: Finland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 364: Finland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 365: Finland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 366: Ireland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 367: Ireland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 368: Ireland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 369: Ireland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 370: Ireland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 371: Ireland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 372: Ireland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 373: Ireland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 374: Ireland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 375: Ireland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 376: Ireland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 377: Ireland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 378: Ireland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 379: Ireland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 380: Turkey atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 381: Turkey atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 382: Turkey atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 383: Turkey atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 384: Turkey atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 385: Turkey atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 386: Turkey atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 387: Turkey atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 388: Turkey atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 389: Turkey atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 390: Turkey atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 391: Turkey atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 392: Turkey atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 393: Turkey atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 394: Greece atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 395: Greece atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 396: Greece atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 397: Greece atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 398: Greece atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 399: Greece atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 400: Greece atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 401: Greece atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 402: Greece atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 403: Greece atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 404: Greece atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 405: Greece atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 406: Greece atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 407: Greece atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 408: Asia Pacific atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)
  • TABLE 409: Asia Pacific atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)
  • TABLE 410: Asia Pacific atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 411: Asia Pacific atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 412: Asia Pacific atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 413: Asia Pacific atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 414: Asia Pacific atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 415: Asia Pacific atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 416: Asia Pacific atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 417: Asia Pacific atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 418: Asia Pacific atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 419: Asia Pacific atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 420: Asia Pacific atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 421: Asia Pacific atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 422: Asia Pacific atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 423: Asia Pacific atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 424: China atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 425: China atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 426: China atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 427: China atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 428: China atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 429: China atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 430: China atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 431: China atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 432: China atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 433: China atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 434: China atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 435: China atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 436: China atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 437: China atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 438: Japan atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 439: Japan atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 440: Japan atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 441: Japan atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 442: Japan atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 443: Japan atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 444: Japan atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 445: Japan atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 446: Japan atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 447: Japan atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 448: Japan atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 449: Japan atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 450: Japan atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 451: Japan atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 452: India atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 453: India atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 454: India atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 455: India atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 456: India atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 457: India atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 458: India atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 459: India atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 460: India atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 461: India atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 462: India atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 463: India atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 464: India atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 465: India atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 466: Australia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 467: Australia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 468: Australia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 469: Australia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 470: Australia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 471: Australia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 472: Australia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 473: Australia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 474: Australia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 475: Australia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 476: Australia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 477: Australia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 478: Australia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 479: Australia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 480: South Korea atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 481: South Korea atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 482: South Korea atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 483: South Korea atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 484: South Korea atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 485: South Korea atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 486: South Korea atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 487: South Korea atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 488: South Korea atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 489: South Korea atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 490: South Korea atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 491: South Korea atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 492: South Korea atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 493: South Korea atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 494: Taiwan atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 495: Taiwan atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 496: Taiwan atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 497: Taiwan atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 498: Taiwan atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 499: Taiwan atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 500: Taiwan atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 501: Taiwan atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 502: Taiwan atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 503: Taiwan atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 504: Taiwan atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 505: Taiwan atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 506: Taiwan atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 507: Taiwan atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 508: New Zealand atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 509: New Zealand atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 510: New Zealand atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 511: New Zealand atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 512: New Zealand atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 513: New Zealand atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 514: New Zealand atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 515: New Zealand atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 516: New Zealand atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 517: New Zealand atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 518: New Zealand atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 519: New Zealand atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 520: New Zealand atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 521: New Zealand atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 522: Singapore atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 523: Singapore atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 524: Singapore atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 525: Singapore atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 526: Singapore atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 527: Singapore atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 528: Singapore atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 529: Singapore atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 530: Singapore atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 531: Singapore atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 532: Singapore atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 533: Singapore atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 534: Singapore atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 535: Singapore atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 536: Latin America atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)
  • TABLE 537: Latin America atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)
  • TABLE 538: Latin America atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 539: Latin America atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 540: Latin America atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 541: Latin America atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 542: Latin America atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 543: Latin America atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 544: Latin America atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 545: Latin America atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 546: Latin America atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 547: Latin America atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 548: Latin America atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 549: Latin America atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 550: Latin America atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 551: Latin America atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 552: Brazil atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 553: Brazil atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 554: Brazil atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 555: Brazil atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 556: Brazil atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 557: Brazil atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 558: Brazil atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 559: Brazil atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 560: Brazil atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 561: Brazil atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 562: Brazil atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 563: Brazil atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 564: Brazil atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 565: Brazil atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 566: Argentina atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 567: Argentina atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 568: Argentina atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 569: Argentina atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 570: Argentina atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 571: Argentina atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 572: Argentina atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 573: Argentina atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 574: Argentina atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 575: Argentina atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 576: Argentina atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 577: Argentina atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 578: Argentina atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 579: Argentina atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 580: Venezuela atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 581: Venezuela atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 582: Venezuela atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 583: Venezuela atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 584: Venezuela atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 585: Venezuela atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 586: Venezuela atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 587: Venezuela atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 588: Venezuela atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 589: Venezuela atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 590: Venezuela atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 591: Venezuela atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 592: Venezuela atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 593: Venezuela atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 594: Columbia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 595: Columbia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 596: Columbia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 597: Columbia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 598: Columbia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 599: Columbia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 600: Columbia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 601: Columbia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 602: Columbia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 603: Columbia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 604: Columbia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 605: Columbia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 606: Columbia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 607: Columbia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 608: Mexico atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 609: Mexico atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 610: Mexico atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 611: Mexico atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 612: Mexico atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 613: Mexico atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 614: Mexico atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 615: Mexico atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 616: Mexico atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 617: Mexico atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 618: Mexico atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 619: Mexico atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 620: Mexico atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 621: Mexico atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 622: MEA atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)
  • TABLE 623: MEA atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)
  • TABLE 624: MEA atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 625: MEA atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 626: MEA atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 627: MEA atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 628: MEA atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 629: MEA atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 630: MEA atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 631: MEA atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 632: MEA atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 633: MEA atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 634: MEA atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 635: MEA atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 636: MEA atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 637: MEA atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 638: South Africa atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 639: South Africa atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 640: South Africa atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 641: South Africa atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 642: South Africa atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 643: South Africa atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 644: South Africa atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 645: South Africa atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 646: South Africa atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 647: South Africa atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 648: South Africa atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 649: South Africa atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 650: South Africa atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 651: South Africa atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 652: Saudi Arabia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 653: Saudi Arabia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 654: Saudi Arabia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 655: Saudi Arabia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 656: Saudi Arabia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 657: Saudi Arabia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 658: Saudi Arabia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 659: Saudi Arabia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 660: Saudi Arabia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 661: Saudi Arabia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 662: Saudi Arabia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 663: Saudi Arabia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 664: Saudi Arabia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 665: Saudi Arabia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 666: UAE atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 667: UAE atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 668: UAE atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 669: UAE atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 670: UAE atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 671: UAE atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 672: UAE atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 673: UAE atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 674: UAE atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 675: UAE atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 676: UAE atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 677: UAE atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 678: UAE atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 679: UAE atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 680: Egypt atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 681: Egypt atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 682: Egypt atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)
  • TABLE 683: Egypt atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)
  • TABLE 684: Egypt atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)
  • TABLE 685: Egypt atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)
  • TABLE 686: Egypt atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)
  • TABLE 687: Egypt atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)
  • TABLE 688: Egypt atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)
  • TABLE 689: Egypt atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)
  • TABLE 690: Egypt atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)
  • TABLE 691: Egypt atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)
  • TABLE 692: Egypt atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 693: Egypt atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

Charts & Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global atrial fibrillation drugs market, 2014 - 2025 (USD Million)
  • FIG. 3: Growth potential analysis, by product
  • FIG. 4: Growth potential analysis, by atrial fibrillation type
  • FIG. 5: Growth potential analysis, by application
  • FIG. 6: Growth potential analysis, by route of administration
  • FIG. 7: Growth potential analysis, by end-use
  • FIG. 8: Global atrial fibrillation prevalence, 2017
  • FIG. 9: North America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 10: Europe proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 11: Asia Pacific proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 12: Latin America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 13: MEA proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 14: North America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 15: Europe proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 16: Asia Pacific proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 17: Latin America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 18: MEA proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
  • FIG. 19: Antiarrhythmic drug pricing analysis
  • FIG. 20: Anticoagulant drug pricing analysis
  • FIG. 21: Major atrial fibrillation anticoagulant drugs market share analysis, 2017
  • FIG. 22: Global atrial fibrillation drugs prescription pattern, 2014 - 2025
  • FIG. 23: Antiarrhythmic drug global prescription pattern, 2014 - 2025
  • FIG. 24: Anticoagulant drug global prescription pattern, 2014 - 2025
  • FIG. 25: Vitamin K antagonists global prescription pattern, 2014 - 2025
  • FIG. 26: Novel oral anticoagulants global prescription pattern, 2014 - 2025
  • FIG. 27: Direct thrombin inhibitors (Dabigatran - Pradaxa) global prescription pattern, 2014 - 2025
  • FIG. 28: Direct factor Xa inhibitors) global prescription pattern, 2014 - 2025
  • FIG. 29: Apixaban (Eliquis) global prescription pattern
  • FIG. 30: Betrixaban (Bevyxxa) global prescription pattern
  • FIG. 31: Edobaxan (Savaysa/Lixiana) global prescription pattern
  • FIG. 32: Rivaroxaban (Xarelto) global prescription pattern
  • FIG. 33: Porter's analysis
  • FIG. 34: Strategy dashboard
  • FIG. 35: PESTEL analysis
目次
Product Code: 3253

Title:
Atrial Fibrillation Drugs Market Size By Products (Antiarrhythmic Drugs, Anticoagulant Drugs {Vitamin K Antagonists, Novel Oral Anticoagulants [Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors]}), By Atrial Fibrillation Type (Paroxysmal, Persistent, Permanent), By Application (Heart Rhythm Control, Heart Rate Control) By Route of Administration (Oral, Injectable) By End-use (Hospitals, Cardiac Centres, Ambulatory Surgical Centres) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Switzerland, Belgium, Czech Republic, Netherlands, Sweden, Hungary, Austria, Portugal, Denmark, Norway, Finland, Ireland, Turkey, Greece, China, Japan, India, Australia, South Korea, Taiwan, New Zealand, Singapore, Brazil, Argentina, Venezuela, Columbia, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Atrial Fibrillation Drugs Market will exceed USD 17.0 billion by 2025; as per a new research report.

Growing number of geriatric population and increasing prevalence of valvular diseases will boost atrial fibrillation drugs industry growth worldwide. Moreover, rising adoption rate of sedentary lifestyle coupled with increasing habit of binge eating among the millennials in developed as well as developing countries will prove to be a high impact rendering factor for the atrial fibrillation drugs market growth during forthcoming years.

However, drug side effects will be one of the major reasons hindering the adoption rates in few developing and under-developed countries. Drug side effects such as severe bleeding, tiredness, etc. will continue to hamper market growth over the forecast timeframe. Also, lack of awareness regarding recent medical drug therapies for the treatment of atrial fibrillation in certain emerging nations might hamper market growth.

Anticoagulant drugs market is forecasted to grow at a lucrative rate of 3.5% over the estimation period. Anticoagulant drugs are most widely used across geographies; the need of using these drugs in the three stages of atrial fibrillation will fuel market growth. Anticoagulants have been known for many years to produce a declining rate of stroke in individuals suffering from atrial fibrillation. Moreover, increasing venture capital investment of firms in the manufacturing of therapeutic drugs will further boost product demand. Hence, the aforementioned factors will boost anticoagulants growth in the global atrial fibrillation drugs market.

The use of atrial fibrillation drugs in paroxysmal condition accounted for revenue of USD 7,095.8 million in the year 2018. Paroxysmal atrial fibrillation occurs when there are irregular electric pathways in the heart and the heart is not pumping enough oxygen-rich blood around the body. The likelihood of suffering from paroxysmal atrial fibrillation increases with age. The most suitable treatment for paroxysmal atrial fibrillation is anticoagulants or blood thinners. Hence, rise in population of baby boomers coupled with increasing prevalence of patients suffering from paroxysmal atrial fibrillation will augment market growth.

Application of atrial fibrillation drugs in heart rhythm control will witness a considerable decline at -2.3% over the forecast timeframe owing to decreasing use of these drugs for restoration and maintenance of sinus rhythm in patients with atrial fibrillation. According to the recent data launch of new oral anticoagulants in the market and rise in preference of physicians to prescribe anticoagulants in case of atrial fibrillation will impede the use of antiarrhythmic drugs in heart rhythm control. As per the American Heart Association, currently around 2.7 million to 6 million Americans suffer from some form of atrial fibrillation. Hence, the rising incidence of the disease will boost atrial fibrillation drugs demand but will witness decline in the use of atrial fibrillation drugs in heart rhythm control.

Injectable atrial fibrillation drugs segment is estimated to grow at 2.4% over the projection period. The growth is attributed to its wide use in patients suffering from acute atrial fibrillation that are forbidden to take drugs orally. Hence, increase in such cases have augmented the segment growth of injectable atrial fibrillation drugs.

Hospitals segment was valued at around USD 6,583.2 million in the year 2018. Hospitals as an end use segment are emerging as one of the preferred healthcare settings for atrial fibrillation care in various countries across the globe. Increasing popularity of this setting in developed countries owing to availability of drug therapies coupled with rising supply agreements of drugs between manufacturing firms and hospitals will strongly propel the growth of atrial fibrillation drugs market in hospitals.

U.S. atrial fibrillation drugs market will witness a growth of 2.4% during the forecast period. Increasing number of major industry players in U.S. facilitates efficient treatment option for patients with atrial fibrillation. Moreover, rising prevalence of chronic diseases such as diabetes, hypertension, etc. will further augment U.S. atrial fibrillation market growth.

China atrial fibrillation drugs market was valued at around USD 805.4 million in the year 2018. The country offers lucrative growth opportunity owing to the unmet needs in large addressable geographical markets. The country's increasing acceptance of private clinics and development of multi-specialty hospitals would propel industry growth over the forecast period.

Industry players having a strong foothold in the atrial fibrillation drugs market include Johnson & Johnson, Pfizer, Sanofi, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo and AstraZeneca. Various recognized firms are entering in sparsely addressed high potential geographies to expand their industry presence. In addition, introduction of drug therapies in developing countries by these companies enable them to expand revenue sources and cater to unmet needs of patient population.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Atrial fibrillation drugs industry 360 degree synopsis, 2014 - 2025 (USD Million)
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Atrial fibrillation type trends
    • 2.1.4. Application trends
    • 2.1.5. Route of Administration trends
    • 2.1.6. End-use trends
    • 2.1.7. Regional trends

Chapter 3. Atrial Fibrillation Drugs Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025 (USD Million)
  • 3.3. Industry impact factors
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increase in prevalence of cardiovascular diseases in developed regions of North America and Europe
      • 3.3.1.2. Rise in demand and need for unmet atrial fibrillation drug therapy
      • 3.3.1.3. Growing geriatric population in Asia Pacific and Latin America
      • 3.3.1.4. Launch of Direct Oral Anticoagulants (DOACs)
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of the anticoagulant drugs
      • 3.3.2.2. Adverse drug side effects
      • 3.3.2.3. Lack of awareness regarding medical therapy in underdeveloped and developing regions
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By atrial fibrillation type
    • 3.4.3. By application
    • 3.4.4. By route of administration
    • 3.4.5. By end-use
  • 3.5. Global atrial fibrillation prevalence, 2017
  • 3.6. Drug approval scenario
    • 3.6.1. U.S. FDA (U.S. Food and Drug Administration)
    • 3.6.2. Europe EMA (European Medicines Agency)
    • 3.6.3. China CFDA (China Drug Administration)
    • 3.6.4. Australia TGA (Australian Therapeutic Goods Administration)
  • 3.7. Proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018
    • 3.7.1. North America
    • 3.7.2. Europe
    • 3.7.3. Asia Pacific
    • 3.7.4. Latin America
    • 3.7.5. Middle East and Africa
  • 3.8. Proportion of atrial fibrillation patients on direct oral anticoagulants (DOACs) drug therapy
    • 3.8.1. North America
    • 3.8.2. Europe
    • 3.8.3. Asia Pacific
    • 3.8.4. Latin America
    • 3.8.5. Middle East and Africa
  • 3.9. Atrial fibrillation drugs pricing analysis
    • 3.9.1. Antiarrhythmic drugs
    • 3.9.2. Anticoagulant drugs
  • 3.10. Major atrial fibrillation anticoagulant drugs market share analysis, 2017
  • 3.11. Global atrial fibrillation drugs prescription pattern, 2014 - 2025
    • 3.11.1. Antiarrhythmic drugs
    • 3.11.2. Anticoagulant drugs
      • 3.11.2.1. Vitamin K antagonists (Warfarin)
      • 3.11.2.2. Novel oral anticoagulants (NOACs)
        • 3.11.2.2.1. Direct thrombin inhibitors (Dabigatran - Pradaxa)
        • 3.11.2.2.2. Direct factor Xa inhibitors
        • 3.11.2.2.2.1. Apixaban (Eliquis)
        • 3.11.2.2.2.2. Betrixaban (Bevyxxa)
        • 3.11.2.2.2.3. Edoxaban (Savaysa/Lixiana)
        • 3.11.2.2.2.4. Rivaroxaban (Xarelto)
  • 3.12. Technology landscape
    • 3.12.1. New atrial fibrillation drugs
      • 3.12.1.1. Antiarrhythmic drugs
      • 3.12.1.2. Anticoagulant drugs
    • 3.12.2. Future of drug therapy in atrial fibrillation
      • 3.12.2.1. Antiarrhythmic drugs
      • 3.12.2.2. Anticoagulant drugs
  • 3.13. Porter's analysis
  • 3.14. Competitive landscape, 2017
    • 3.14.1. Strategy dashboard
  • 3.15. PESTEL analysis

Chapter 4. Atrial Fibrillation Drugs Market, By Product

  • 4.1. Global atrial fibrillation drugs market share, by product, 2018 & 2025
  • 4.2. Antiarrhythmic Drugs
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. Anticoagulant Drugs
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.3.2. Vitamin K antagonists (VKA)
      • 4.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
    • 4.3.3. Novel oral anticoagulants (NOACs)
      • 4.3.3.1. Market size, by region, 2014 - 2025 (USD Million)
      • 4.3.3.2. Direct thrombin inhibitors
        • 4.3.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
      • 4.3.3.3. Direct factor Xa inhibitors
        • 4.3.3.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Atrial Fibrillation Drugs Market, By Atrial Fibrillation Type

  • 5.1. Global atrial fibrillation drugs market share, by atrial fibrillation type, 2018 & 2025
  • 5.2. Paroxysmal
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Persistent
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.4. Permanent
    • 5.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Atrial Fibrillation Drugs Market, By Application

  • 6.1. Global atrial fibrillation drugs market share, by application, 2018 & 2025
  • 6.2. Heart Rhythm Control
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Heart Rate Control
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Atrial Fibrillation Drugs Market, By Route of Administration

  • 7.1. Global atrial fibrillation drugs market share, by route of administration, 2018 & 2025
  • 7.2. Oral
    • 7.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 7.3. Injectable
    • 7.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 8. Atrial fibrillation Drugs Market, By End-use

  • 8.1. Global atrial fibrillation drugs market share by end-use, 2018 & 2025
  • 8.2. Hospitals
    • 8.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 8.3. Cardiac Centers
    • 8.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 8.4. Ambulatory Surgical Centers
    • 8.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 8.5. Others
    • 8.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 9. Atrial Fibrillation Drugs Market, By Region

  • 9.1. Global atrial fibrillation drugs market share by region, 2018 & 2025
  • 9.2. North America
    • 9.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 9.2.2. Market size, by product, 2014 - 2025 (USD Million)
      • 9.2.2.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.2.2.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
    • 9.2.3. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
    • 9.2.4. Market size, by application, 2014 - 2025 (USD Million)
    • 9.2.5. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 9.2.6. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.2.7.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.2.7.1.1.1. Market size, by Novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.2.7.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.2.7.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.2.7.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.2.7.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.2.8. Canada
      • 9.2.8.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.2.8.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.2.8.1.1.1. Market size, by Novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.2.8.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.2.8.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.2.8.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.2.8.5. Market size, by end-use, 2014 - 2025 (USD Million)
  • 9.3. Europe
    • 9.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 9.3.2. Market size, by product, 2014 - 2025 (USD Million)
      • 9.3.2.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.2.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
    • 9.3.3. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
    • 9.3.4. Market size, by application, 2014 - 2025 (USD Million)
    • 9.3.5. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 9.3.6. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.7. Germany
      • 9.3.7.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.7.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.7.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.7.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.7.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.7.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.7.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.8. UK
      • 9.3.8.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.8.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.8.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.8.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.8.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.8.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.8.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.9. France
      • 9.3.9.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.9.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.9.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.9.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.9.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.9.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.9.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.10. Spain
      • 9.3.10.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.10.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.10.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.10.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.10.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.10.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.10.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.11. Italy
      • 9.3.11.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.11.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.11.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.11.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.11.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.11.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.11.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.12. Russia
      • 9.3.12.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.12.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.12.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.12.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.12.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.12.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.12.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.13.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.13.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.13.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.13.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.13.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.13.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.14. Switzerland
      • 9.3.14.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.14.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.14.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.14.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.14.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.14.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.14.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.15. Belgium
      • 9.3.15.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.15.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.15.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.15.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.15.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.15.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.15.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.16. Czech Republic
      • 9.3.16.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.16.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.16.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.16.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.16.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.16.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.16.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.17. Netherlands
      • 9.3.17.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.17.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.17.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.17.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.17.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.17.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.17.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.18. Sweden
      • 9.3.18.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.18.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.18.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.18.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.18.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.18.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.18.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.19. Hungary
      • 9.3.19.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.19.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.19.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.19.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.19.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.19.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.19.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.20. Austria
      • 9.3.20.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.20.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.20.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.20.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.20.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.20.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.20.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.21. Portugal
      • 9.3.21.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.21.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.21.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.21.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.21.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.21.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.21.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.22. Denmark
      • 9.3.22.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.22.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.22.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.22.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.22.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.22.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.22.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.23. Norway
      • 9.3.23.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.23.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.23.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.23.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.23.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.23.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.23.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.24. Finland
      • 9.3.24.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.24.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.24.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.24.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.24.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.24.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.24.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.25. Ireland
      • 9.3.25.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.25.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.25.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.25.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.25.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.25.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.25.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.26. Turkey
      • 9.3.26.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.26.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.26.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.26.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.26.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.26.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.26.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.3.27. Greece
      • 9.3.27.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.3.27.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.3.27.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.3.27.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.3.27.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.3.27.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.3.27.5. Market size, by end-use, 2014 - 2025 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 9.4.2. Market size, by product, 2014 - 2025 (USD Million)
      • 9.4.2.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.2.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
    • 9.4.3. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
    • 9.4.4. Market size, by application, 2014 - 2025 (USD Million)
    • 9.4.5. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 9.4.6. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.7. China
      • 9.4.7.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.7.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.7.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.7.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.7.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.7.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.7.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.8. Japan
      • 9.4.8.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.8.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.8.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.8.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.8.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.8.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.8.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.9. India
      • 9.4.9.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.9.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.9.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.9.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.9.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.9.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.9.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.10. Australia
      • 9.4.10.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.10.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.10.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.10.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.10.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.10.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.10.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.11. South Korea
      • 9.4.11.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.11.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.11.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.11.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.11.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.11.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.11.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.12. Taiwan
      • 9.4.12.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.12.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.12.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.12.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.12.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.12.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.12.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.13. New Zealand
      • 9.4.13.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.13.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.13.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.13.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.13.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.13.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.13.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.4.14. Singapore
      • 9.4.14.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.4.14.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.4.14.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.4.14.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.4.14.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.4.14.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.4.14.5. Market size, by end-use, 2014 - 2025 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 9.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 9.5.2.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.2.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
    • 9.5.3. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
    • 9.5.4. Market size, by application, 2014 - 2025 (USD Million)
    • 9.5.5. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 9.5.6. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.5.7.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.7.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.5.7.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.5.7.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.5.7.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.5.7.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.5.8.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.8.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.5.8.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.5.8.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.5.8.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.5.8.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.5.9. Venezuela
      • 9.5.9.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.5.9.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.9.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.5.9.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.5.9.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.5.9.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.5.9.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.5.10. Columbia
      • 9.5.10.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.5.10.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.10.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.5.10.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.5.10.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.5.10.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.5.10.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.5.11. Mexico
      • 9.5.11.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.5.11.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.5.11.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.5.11.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.5.11.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.5.11.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.5.11.5. Market size, by end-use, 2014 - 2025 (USD Million)
  • 9.6. Middle East & Africa
    • 9.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 9.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 9.6.2.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.6.2.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
    • 9.6.3. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
    • 9.6.4. Market size, by application, 2014 - 2025 (USD Million)
    • 9.6.5. Market size, by route of administration, 2014 - 2025 (USD Million)
    • 9.6.6. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.6.7. South Africa
      • 9.6.7.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.6.7.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.6.7.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.6.7.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.6.7.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.6.7.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.6.7.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.6.8. Saudi Arabia
      • 9.6.8.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.6.8.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.6.8.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.6.8.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.6.8.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.6.8.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.6.8.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.6.9. UAE
      • 9.6.9.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.6.9.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.6.9.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.6.9.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.6.9.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.6.9.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.6.9.5. Market size, by end-use, 2014 - 2025 (USD Million)
    • 9.6.10. Egypt
      • 9.6.10.1. Market size, by product, 2014 - 2025 (USD Million)
        • 9.6.10.1.1. Market size, by anticoagulant drugs, 2014 - 2025 (USD Million)
        • 9.6.10.1.1.1. Market size, by novel oral anticoagulants, 2014 - 2025 (USD Million)
      • 9.6.10.2. Market size, by atrial fibrillation type, 2014 - 2025 (USD Million)
      • 9.6.10.3. Market size, by application, 2014 - 2025 (USD Million)
      • 9.6.10.4. Market size, by route of administration, 2014 - 2025 (USD Million)
      • 9.6.10.5. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 10. Company Profiles

  • 10.1. AstraZeneca
    • 10.1.1. Business overview
    • 10.1.2. Financial data
    • 10.1.3. Product landscape
    • 10.1.4. Strategic outlook
    • 10.1.5. SWOT analysis
  • 10.2. Boehringer Ingelheim
    • 10.2.1. Business overview
    • 10.2.2. Financial data
    • 10.2.3. Product landscape
    • 10.2.4. Strategic outlook
    • 10.2.5. SWOT analysis
  • 10.3. Bristol-Myers Squibb
    • 10.3.1. Business overview
    • 10.3.2. Financial data
    • 10.3.3. Product landscape
    • 10.3.4. Strategic outlook
    • 10.3.5. SWOT analysis
  • 10.4. Daiichi Sankyo
    • 10.4.1. Business overview
    • 10.4.2. Financial data
    • 10.4.3. Product landscape
    • 10.4.4. Strategic outlook
    • 10.4.5. SWOT analysis
  • 10.5. GlaxoSmithKline
    • 10.5.1. Business overview
    • 10.5.2. Financial data
    • 10.5.3. Product landscape
    • 10.5.4. Strategic outlook
    • 10.5.5. SWOT analysis
  • 10.6. Johnson and Johnson (JanssenOrtho)
    • 10.6.1. Business overview
    • 10.6.2. Financial data
    • 10.6.3. Product landscape
    • 10.6.4. Strategic outlook
    • 10.6.5. SWOT analysis
  • 10.7. Mitsubishi Tanabe Pharma
    • 10.7.1. Business overview
    • 10.7.2. Financial data
    • 10.7.3. Product landscape
    • 10.7.4. Strategic outlook
    • 10.7.5. SWOT analysis
  • 10.8. Pfizer
    • 10.8.1. Business overview
    • 10.8.2. Financial data
    • 10.8.3. Product landscape
    • 10.8.4. Strategic outlook
    • 10.8.5. SWOT analysis
  • 10.9. Portola Pharmaceuticals
    • 10.9.1. Business overview
    • 10.9.2. Financial data
    • 10.9.3. Product landscape
    • 10.9.4. Strategic outlook
    • 10.9.5. SWOT analysis
  • 10.10. Sanofi
    • 10.10.1. Business overview
    • 10.10.2. Financial data
    • 10.10.3. Product landscape
    • 10.10.4. Strategic outlook
    • 10.10.5. SWOT analysis
Back to Top